TradingMenu expanded
Forge Markets Browse Companies
DataMenu expanded
Forge Data IPO Stock Tracker
SolutionsMenu expanded
For Institutions For Shareholders For Investors For Companies In Europe
InsightsMenu expanded
All Insights Blog Reports Videos Webinars
Popular Topics
Buying Pre-IPO Shares Selling Pre-IPO Shares Private Market Reports Private Market Data & Analytics Startup News
AboutMenu expanded
About Us Team Investor Relations People & Culture Careers FAQs
Log In Sign Up
Trading Menu expandedTrading
Forge Markets
Browse Companies
Data Menu expandedData
Forge Data
IPO Stock Tracker
Solutions Menu expandedSolutions
For Institutions
For Shareholders
For Investors
For Companies
In Europe
Insights Menu expandedInsights
All Insights
Blog
Reports
Videos
Webinars
Popular Topics
Buying Pre-IPO Shares
Selling Pre-IPO Shares
Private Market Reports
Private Market Data & Analytics
Startup News
About Menu expandedAbout
About Us
Team
Investor Relations
People & Culture
Careers
FAQs
Trading / Browse Companies / Generation Bio Stock

Generation Bio Stock

generationbio.comHealthcareFounded: 2016Funding to Date: $125.37MM

Generation Bio is an innovative genetic medicines company focused on creating a new class of gene therapy to provide durable, redosable treatments for patients suffering from both rare and prevalent diseases.

Learn more about Generation Bio IPO
Register for Details

For more details on financing and valuation for Generation Bio, register or login.

Please provide a valid email address.

By registering, you agree to Forge’s Terms of Use. Already registered? Log in

OverviewFinancingsValuation

Enterprise Value (based on primary financings)

Powered by Forge Data
Enterprise Value

View Enterprise Value for Generation Bio.

Register Today

Team

Management Team

Thomas Graney
Chief Financial Officer
Will McCarthy
Chief Business Officer
Jason Rhodes
Chairman & Co-Founder
Mark Angelino Ph.D
Chief Operating Officer & Co-Founder
Robert Kotin Ph.D
Co-Founder & Head of Discovery
Geoffrey McDonough MD
Chief Executive Officer, President & Board Member
Jennifer Elliott Ph.D
Vice President, Head of Legal Affairs and Intellectual Property

Board Members

Donald Nicholson Ph.D
Anthony Quinn Ph.D
Geoffrey McDonough MD
Gustav Christensen
Jeffrey Jonas MD
Catherine Stehman-Breen MD
Jason Rhodes

Other companies like Generation Bio in the Healthcare sector

Neuralink
Sector
Healthcare
Last Round Est. Valuation
$2.15B
Colossal Biosciences
Sector
Healthcare
 
 
Altos Labs
Sector
Healthcare
Last Round Est. Valuation
$3.67B
Synchron
Sector
Healthcare
Last Round Est. Valuation
$400.53MM
Grail
Sector
Healthcare
Last Round Est. Valuation
$4.26B
OURA
Sector
Healthcare
 
 
Mammoth Biosciences
Sector
Healthcare
Last Round Est. Valuation
$1.08B
Cytonics
Sector
Healthcare
 
 
Precision Neuroscience
Sector
Healthcare
 
 

News

Xconomy 01/13/2020
Xconomy: Generation Bio Pockets $110M for Next Wave of Gene Therapy, IPO Plans
JP Morgan’s annual healthcare conference convenes in San Francisco this week and Generation Bio CEO Geoff McDonough is betting gene therapy will be among
FINSMES 01/10/2020
Generation Bio Raises $110M in Series C Financing | FinSMEs
Generation Bio, a Cambridge, MA-based gene therapy company, closed a $110m Series C financing. round led by T. Rowe Price funds and accounts
Business Wire 10/29/2019
Generation Bio Welcomes Steven Dowdy, Ph.D., to its Scientific Advisory Board
Generation Bio announced that Steven Dowdy, Ph.D., has joined its Scientific Advisory Board.

Trending Companies

Frequently Asked Questions